Back to Search
TOMASZ BEER, MD
MD
Medical Oncology Physician
NPI: 1669487179IndividualAccepts Medicare
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1991
Research & Publications (20)
Southwest Oncology Group phase II study of irinotecan in patients with advanced transitional cell carcinoma of the urothelium that progressed after platinum-based chemotherapy.
PMID 18501081·Clin Genitourin Cancer·2008
3-trial
C-reactive protein as a prognostic marker for men with androgen-independent prostate cancer: results from the ASCENT trial.
PMID 18428198·Cancer·2008
4-observational
Southwest Oncology Group phase II study of ispinesib in androgen-independent prostate cancer previously treated with taxanes.
PMID 18824433·Clin Genitourin Cancer·2008
3-trial
Intermittent chemotherapy in patients with metastatic androgen-independent prostate cancer: results from ASCENT, a double-blinded, randomized comparison of high-dose calcitriol plus docetaxel with placebo plus docetaxel.
PMID 17960793·Cancer·2008
4-observational
Darbepoetin alfa administered every 4 weeks for anemia in patients with advanced prostate cancer.
PMID 17645830·Clin Genitourin Cancer·2007
8-other
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel.
PMID 17618407·Invest New Drugs·2007
3-trial
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators.
PMID 17308271·J Clin Oncol·2007
4-observational
Phase I study of weekly DN-101, a new formulation of calcitriol, in patients with cancer.
PMID 17066293·Cancer Chemother Pharmacol·2007
3-trial
Dose-escalated abarelix in androgen-independent prostate cancer: a phase I study.
PMID 17001181·Anticancer Drugs·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239 - Phone
- (503) 494-6594
Quick Facts
- NPI
- 1669487179
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile